Published in Curr Alzheimer Res on July 01, 2007
Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging (2007) 2.13
Alzheimer's disease and anesthesia. Front Neurosci (2011) 1.00
Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model. Alzheimers Dement (2011) 0.97
Isoflurane increases neuronal cell death vulnerability by downregulating miR-214. PLoS One (2013) 0.86
Isoflurane exposure during mid-adulthood attenuates age-related spatial memory impairment in APP/PS1 transgenic mice. PLoS One (2012) 0.83
Effect of synthetic aβ peptide oligomers and fluorinated solvents on Kv1.3 channel properties and membrane conductance. PLoS One (2012) 0.80
Sevoflurane impairs acquisition learning and memory function in transgenic mice model of Alzheimer's disease by induction of hippocampal neuron apoptosis. Int J Clin Exp Med (2015) 0.77
Cell line specific modulation of extracellular aβ42 by Hsp40. PLoS One (2012) 0.76
Halothane increases neuronal cell death vulnerability by downregulating miR-214 and upregulating Bax. Int J Clin Exp Med (2013) 0.75
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A (1997) 4.03
Asparagine-mediated self-association of a model transmembrane helix. Nat Struct Biol (2000) 2.97
Protein design, a minimalist approach. Science (1989) 2.66
Polar side chains drive the association of model transmembrane peptides. Proc Natl Acad Sci U S A (2001) 2.64
Design and synthesis of multi-haem proteins. Nature (1994) 2.59
Violence in America. Effective solutions. J Med Assoc Ga (1995) 2.38
pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Biochemistry (2000) 2.14
Mechanism for proton conduction of the M(2) ion channel of influenza A virus. J Biol Chem (2000) 2.13
Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry (1999) 2.02
Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem (1987) 1.89
Binding of halothane to serum albumin demonstrated using tryptophan fluorescence. Anesthesiology (1995) 1.76
Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (2001) 1.74
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein. J Biol Chem (1999) 1.67
Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry (1990) 1.59
Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry (1994) 1.53
Fluorescence studies of the secondary structure and orientation of a model ion channel peptide in phospholipid vesicles. Biochemistry (1992) 1.49
Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology (1993) 1.47
In vivo function and membrane binding properties are correlated for Escherichia coli lamB signal peptides. Science (1985) 1.40
A helical-dipole model describes the single-channel current rectification of an uncharged peptide ion channel. Proc Natl Acad Sci U S A (1994) 1.40
The role of protonation and metal chelation preferences in defining the properties of mercury-binding coiled coils. J Mol Biol (1998) 1.37
Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys J (1998) 1.34
Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptides. Proc Natl Acad Sci U S A (1993) 1.33
Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles. Biochemistry (1991) 1.33
Exploration of the structural features defining the conduction properties of a synthetic ion channel. Biophys J (1999) 1.27
Charge selectivity of the designed uncharged peptide ion channel Ac-(LSSLLSL)3-CONH2. Biophys J (1995) 1.21
Conformationally constrained alpha-helical peptide models for protein ion channels. Biopolymers (1990) 1.19
Two possible conducting states of the influenza A virus M2 ion channel. FEBS Lett (2000) 1.09
Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest (1991) 1.07
A designed four-alpha-helix bundle that binds the volatile general anesthetic halothane with high affinity. Biophys J (2000) 1.07
A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase. Biochemistry (2001) 1.06
Quantitative autoradiography of halothane binding in rat brain. J Pharmacol Exp Ther (1998) 1.02
A new data analysis method to determine binding constants of small molecules to proteins using equilibrium analytical ultracentrifugation with absorption optics. Anal Biochem (2001) 1.01
From synthetic coiled coils to functional proteins: automated design of a receptor for the calmodulin-binding domain of calcineurin. J Mol Biol (1998) 0.96
General anesthetic binding to gramicidin A: the structural requirements. Biophys J (2000) 0.96
Proton and metal ion-dependent assembly of a model diiron protein. Protein Sci (2001) 0.95
Characterization of Actinobacillus actinomycetemcomitans leukotoxin pore formation in HL60 cells. Biochim Biophys Acta (1998) 0.92
Spinal cord decompression sickness after standard U.S. Navy air decompression. Mil Med (1986) 0.91
Minimum structural requirement for an inhalational anesthetic binding site on a protein target. Biochim Biophys Acta (1996) 0.87
Air and nitrox saturation decompression: a report of 4 schedules and 77 subjects. Undersea Biomed Res (1985) 0.85
Saturable binding of halothane to rat brain synaptosomes. Proc Natl Acad Sci U S A (1992) 0.83
Progression of and recovery from pulmonary oxygen toxicity in humans exposed to 5 ATA air. Aviat Space Environ Med (1987) 0.82
Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry (2000) 0.81
Direct ascent from shallow air saturation exposures. Undersea Biomed Res (1986) 0.81
Halothane, an inhalational anesthetic agent, increases folding stability of serum albumin. Biochim Biophys Acta (1999) 0.80
Predictability of weak binding from X-ray crystallography: inhaled anesthetics and myoglobin. Biochemistry (2001) 0.79
Volatile anesthetics alter protein stability. Toxicol Lett (1998) 0.77
De novo design of a pentameric coiled-coil: decoding the motif for tetramer versus pentamer formation in water-soluble phospholamban. J Pept Res (2005) 0.77
Heterogeneous halothane binding in the SR Ca2+-ATPase. FEBS Lett (1997) 0.77
A noble approach to mechanisms. Anesth Analg (1998) 0.77
Gamma-aminobutyric acid enhancement of halothane binding in rat cerebellum. Neurosci Lett (2000) 0.76
What are "relevant" concentrations? Anesthesiology (2001) 0.76
Cardiac arrhythmias and heart rate changes in prolonged hyperbaric air exposures. Undersea Biomed Res (1984) 0.75
Alcohol and bends. Undersea Biomed Res (1989) 0.75
Tests of anesthesia relevance. Anesth Analg (1995) 0.75
The role of monitoring venous gas emboli after decompression. Undersea Biomed Res (1985) 0.75
Determination of the hydrophobicity of local anesthetic agents. Anal Biochem (2001) 0.75
Hematologic and hemostatic changes with repetitive air diving. Aviat Space Environ Med (1984) 0.75
Elemental composition of lamellar bodies from fetal and adult human lung. Am J Respir Cell Mol Biol (1995) 0.75
Latency in onset of decompression sickness on direct ascent from air saturation. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.75